Combination therapy has become a common way to treat many cancers, as the complexity presented by certain types requires a variety of therapies to attack it.
Christopher Haqq MD, PhD, discusses his research at ASCO 2019.
Rod Humerickhouse, MD, PhD, discusses the latest research at ASCO 2019.
Daniel James George, MD
Alexander Spira MD, PhD, discusses his research at the ASCO 2019 meeting.
Michael Hallek, MD, discusses data at the ASCO 2019 meeting in Chicago, IL.
The Problem Rotator cuff repair results in predictable pain relief and a variable return of function in the majority of patients. However, it may take up to a year to achieve maximum improvement in shoulder strength and function. In certain cases patients may continue to experience pain and weakness in the shoulder following rotator cuff…
Treatment with single-agent ibrutinib was well-tolerated and provided durable responses in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).
For the treatment of patients with advanced urothelial cancer, pembrolizumab demonstrated anti-tumor activity and an acceptable safety profile.
Treatment with diagnostic laparoscopy rather than primary surgery may lower the rate of futile laparotomies among women with suspected advanced ovarian cancer.
